Key Points
- Director Kristina Leslie sold 1,200 Hinge Health shares at an average price of $88.23, generating $105,876. Following the transaction, she retained 30,387 shares.
- Hinge Health shares rose 3.3% to open at $88.44, near their 52-week high of $93.13. The company recently reported quarterly EPS of $0.59, beating estimates of $0.28, while revenue increased 53% year over year to $212.82 million.
- Analysts maintain a “Moderate Buy” consensus rating, with an average price target of $100.57; several firms recently raised their targets, including KeyCorp to $125 and RBC to $110.
Hinge Health Inc. (NYSE:HNGE - Get Free Report) Director Kristina Leslie sold 1,200 shares of the company's stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $88.23, for a total value of $105,876.00. Following the completion of the transaction, the director directly owned 30,387 shares in the company, valued at approximately $2,681,045.01. The trade was a 3.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Hinge Health Trading Up 3.3%
Hinge Health stock opened at $88.44 on Friday. The stock has a market cap of $7.14 billion, a P/E ratio of 69.09 and a beta of 1.30. The stock has a 50 day moving average of $81.40 and a 200-day moving average of $58.29. Hinge Health Inc. has a 52 week low of $30.08 and a 52 week high of $93.13.
Hinge Health (NYSE:HNGE - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.31. The business had revenue of $212.82 million during the quarter. Hinge Health had a net margin of 15.15% and a return on equity of 51.60%. The firm's quarterly revenue was up 53.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.59 EPS. As a group, equities analysts predict that Hinge Health Inc. will post 1.25 earnings per share for the current fiscal year.
Institutional Trading of Hinge Health
A number of institutional investors and hedge funds have recently modified their holdings of HNGE. Wells Fargo & Company MN lifted its position in shares of Hinge Health by 160.0% in the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company's stock worth $25,000 after buying an additional 336 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Hinge Health during the 4th quarter valued at about $26,000. Nykredit A S acquired a new stake in Hinge Health during the second quarter worth about $29,000. CENTRAL TRUST Co acquired a new stake in Hinge Health during the first quarter worth about $37,000. Finally, First Horizon Corp lifted its holdings in Hinge Health by 163.9% in the fourth quarter. First Horizon Corp now owns 855 shares of the company's stock worth $40,000 after acquiring an additional 531 shares during the last quarter.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on HNGE shares. Raymond James Financial upped their target price on shares of Hinge Health from $70.00 to $80.00 and gave the company an "outperform" rating in a research note on Monday, June 15th. Citizens Jmp boosted their price objective on Hinge Health from $96.00 to $107.00 and gave the company a "market outperform" rating in a report on Wednesday, August 5th. KeyCorp upped their price objective on Hinge Health from $90.00 to $125.00 and gave the company an "overweight" rating in a research note on Monday, July 13th. Piper Sandler restated an "overweight" rating on shares of Hinge Health in a research note on Wednesday, June 10th. Finally, Royal Bank Of Canada increased their target price on Hinge Health from $75.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Hinge Health has a consensus rating of "Moderate Buy" and a consensus target price of $100.57.
Read Our Latest Stock Report on Hinge Health
About Hinge Health
(
Get Free Report)
Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.
Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
